The association between type 2 diabetes and anhedonic subtype of major depression in hypertensive individuals. Issue 2 (13th January 2022)

• Record Type: Journal Article
• Authors: Willame, Hadrien; Wacquier, Benjamin; Point, Camille; Dosogne, Marjorie; Al Faker, Mohammed; Loas, Gwenolé; Hein, Matthieu
• Is Part Of: Journal of clinical hypertension. Volume 24:Issue 2(2022)
• Page Start: 156
• Page End: 166
• Publication Date: 2022-01-13
• Subjects: diabetes -- epidemiology -- hypertension -- general -- major depression -- risk assessment; Hypertension -- Periodicals; 616.132
• DOI: 10.1111/jch.14411
• Languages: English
• ISSNs: 1524-6175

Abstract

Abstract: Given the limited data in the literature, the aim of this study was to investigate the association between type 2 diabetes and anhedonic subtype of major depression in hypertensive individuals. Demographic and polysomnographic data from 323 hypertensive individuals recruited from the database of the Erasme Hospital Sleep Laboratory were analysed. Only individuals with a diagnosis of type 2 diabetes according to the diagnostic criteria of the American Diabetes Association at admission were included in the "diabetes group". Logistic regression analyses were used to study the association between type 2 diabetes and anhedonic subtype of major depression in hypertensive individuals. The rate of type 2 diabetes was 18.9% in our sample of hypertensive individuals. After adjusting for major confounding factors, multivariate logistic regression analyses demonstrated that unlike the non‐anhedonic subtype of major depression, only the anhedonic subtype of major depression was significantly associated with higher likelihood of having type 2 diabetes in hypertensive individuals. In this study, the authors demonstrated that the anhedonic subtype of major depression is significantly associated with type 2 diabetes in hypertensive individuals, which could potentially open up new perspectives for the development of therapeutic strategies complementary to conventional treatments for type 2 diabetes in this subpopulation at high risk of complications related to the co‐occurrence of this metabolic disorder.